Eli Lilly and (NYSE:LLY) major shareholder Lilly Endowment Inc sold 150,000 shares of Eli Lilly and stock on the open market in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $58.64, for a total value of $8,796,000.00. Following the sale, the insider now directly owns 135,520,804 shares in the company, valued at approximately $7,946,939,947. Eli Lilly and Co (NYSE:LLY) shares after opening at $59.20 moved to $59.67 on last trade day and at the end of the day closed at $59.62. Company price to sales ratio in past twelve months was calculated as 2.89 and price to cash ratio as 12.37. Eli Lilly and Co (NYSE:LLY) showed a negative weekly performance of -0.68%.
Amgen (NASDAQ:AMGN) CFO A Kelly Michael sold 2,065 shares of Amgen stock on the open market in a transaction dated Monday, April 28th. The stock was sold at an average price of $110.45, for a total value of $228,079.25. Following the sale, the chief financial officer now directly owns 41,041 shares in the company, valued at approximately $4,532,978. Amgen, Inc. (NASDAQ:AMGN) shares advanced 0.38% in last trading session and ended the day on $111.90. AMGN return on equity ratio is recorded as 21.70% and its return on assets is 7.80%. Amgen, Inc. (NASDAQ:AMGN) yearly performance is 6.81%.
Thermo Fisher Scientific (NYSE:TMO) SVP Thomas W. Loewald sold 8,688 shares of the stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $114.49, for a total value of $994,689.12. Following the completion of the sale, the senior vice president now directly owns 41,307 shares in the company, valued at approximately $4,729,238. Thermo Fisher Scientific Inc. (NYSE:TMO) shares moved up 0.92% in last trading session and was closed at $114.64, while trading in range of $113.31 – $115.25. Thermo Fisher Scientific Inc. (NYSE:TMO) year to date (YTD) performance is 3.07%.
Tenet Healthcare Corp (NYSE:THC) CEO Trevor Fetter sold 57,735 shares of Tenet Healthcare Corp stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $45.00, for a total value of $2,598,075.00. Following the completion of the sale, the chief executive officer now directly owns 999,184 shares of the company’s stock, valued at approximately $44,963,280. Tenet Healthcare Corp (NYSE:THC) weekly performance is 13.31%. On last trading day company shares ended up $45.71. Tenet Healthcare Corp (NYSE:THC) distance from 50-day simple moving average (SMA50) is 8.28%. Analysts mean target price for the company is $48.97.